ANTIPODES PARTNERS Ltd: AMZN position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on AMZN, newest first. How the timeline and the estimate are built.
ANTIPODES PARTNERS Ltd held 996,493 AMZN shares at 2026-06-30 per its 13F-HR filed 2026-08-06.
the latest 13F is the newest step
- period ended2026-06-3013F 996,493 sharesChange vs previous 13F -200,281 shares
4.35% of the 13F portfolio, value $237,504,142.
13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,196,774 sharesChange vs previous 13F +220,450 shares
4.8% of the 13F portfolio, value $249,252,121.
13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 976,324 sharesChange vs previous 13F +300,716 shares
4.73% of the 13F portfolio, value $225,372,003.
13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 675,608 sharesChange vs previous 13F -108,722 shares
3.33% of the 13F portfolio, value $148,354,440.
13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 784,330 sharesChange vs previous 13F -18,243 shares
5.34% of the 13F portfolio, value $172,087,287.
13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 802,573 sharesChange vs previous 13F +159,655 shares
4.78% of the 13F portfolio, value $152,709,791.
13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 642,918 sharesChange vs previous 13F -355,893 shares
4.9% of the 13F portfolio, value $141,061,171.
13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 998,811 sharesChange vs previous 13F not available
6.45% of the 13F portfolio, value $186,121,867.
13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).